There have been significant advances in the treatment of hepatitis C, which impacts people who use substances to a higher degree than the general population. Screening for hepatitis C is a requirement for any SUD treatment program that receives block grant funding. This webinar will help any SUD treatment provider or staff who is working with people who use drugs and may be at risk of hepatitis C.
Dr. Hermione Hurley is an Associate Professor at University of Colorado, working at Denver Health as a Physician of Infectious Disease and Addiction Medicine. Her interest in providing low barrier care was prompted after observing poor health outcomes for people released from incarceration as they transitioned back into the community. Her position is supported by the departments of Psychiatry, Public Health and Medicine enabling integrated treatment of infection in opioid treatment programs, and substance use treatment for people living with HIV.
Dr. Sarah Rowan is the Associate Director of HIV and Viral Hepatitis Prevention at the Public Health Institute at Denver Health and an Associate Professor in the Division of Infectious Diseases at the University of Colorado Denver. She is board certified in infectious diseases and specializes in the care of patients with HIV, hepatitis C, and sexually transmitted infections. Dr. Rowan’s research focuses on optimizing public health efforts to diagnose, treat, and prevent HIV and hepatitis C (HCV). She also serves as the Associate Director for Public and Community Health for the Mentored Scholarly Activity Program in the University of Colorado School of Medicine.
